Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.56 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6026850 | 0.91 | ELANE (0.60) | ELANENR1H2SMN1; SMN2KMT2ANPC1 | |
| SCHEMBL6026715 | 0.90 | ELANE (0.63) | ELANEKMT2AESR1 | |
| SCHEMBL6026762 | 0.89 | NR1H2 (0.59) | ELANENR1H2NR1H3CYP3A4SMN1; SMN2 | |
| SCHEMBL6026870 | 0.84 | ELANE (0.46) | ELANENR1H2NR1H3SMN1; SMN2TDP1 | |
| SCHEMBL6026766 | 0.83 | KMT2A (0.45) | ELANENR1H2NR1H3SMN1; SMN2TDP1 | |
| SCHEMBL6026095 | 0.81 | ELANE (0.48) | ELANENR1H2NR1H3SMN1; SMN2TDP1 | |
| SCHEMBL6026747 | 0.81 | ELANE (0.48) | ELANENR1H2NR1H3SMN1; SMN2TDP1 | |
| SCHEMBL7965056 | 0.79 | CYP3A4 (0.51) | ELANECYP3A4SMN1; SMN2TDP1KMT2A | |
| SCHEMBL6026922 | 0.79 | ELANE (0.52) | ELANESMN1; SMN2TDP1KMT2ANPC1 | |
| SCHEMBL6027161 | 0.78 | ELANE (0.46) | ELANENR1H2NR1H3SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7067523-B2 | Use of pyrone carboxylates for controlling pests | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-06-27 | — | — | US | disclosed |
| US-20050159479-A1 | Use of pyrone carboxylates for controlling pests | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-21 | — | — | US | disclosed |
| CN-1205198-C | Cyclic ketone derivative and pharmaceutical use thereof | TORAY INDUSTRIES (JP) | 2005-06-08 | — | — | CN | disclosed |
| WO-2003099008-A1 | USE OF PYRONE CARBOXYLATES FOR CONTROLLING PESTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-04 | — | — | WO | disclosed |
| US-6184245-B1 | Cyclic ketone derivatives and their medical applications | TORAY INDUSTRIES INC. (JP) | 2001-02-06 | — | — | US | disclosed |
| CN-1242770-A | Cyclic ketone derivative and pharmaceutical use thereof | TORAY INDUSTRIES (JP) | 2000-01-26 | — | — | CN | disclosed |
| EP-0962456-A1 | CYCLIC KETONE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 1999-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159479-A1 | Use of pyrone carboxylates for controlling pests | TET1, TET3, CNPY3 | ELANE 2080/4885NR1H2 3082/4885NR1H3 3009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.